These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17688420)

  • 1. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?
    Paterna S; Gaspare P; Fasullo S; Sarullo FM; Di Pasquale P
    Clin Sci (Lond); 2008 Feb; 114(3):221-30. PubMed ID: 17688420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure.
    Parrinello G; Di Pasquale P; Licata G; Torres D; Giammanco M; Fasullo S; Mezzero M; Paterna S
    J Card Fail; 2009 Dec; 15(10):864-73. PubMed ID: 19944363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): a pilot study.
    Colin-Ramirez E; McAlister FA; Zheng Y; Sharma S; Armstrong PW; Ezekowitz JA
    Am Heart J; 2015 Feb; 169(2):274-281.e1. PubMed ID: 25641537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
    Parrinello G; Paterna S; Di Pasquale P; Torres D; Mezzero M; Cardillo M; Fasullo S; La Rocca G; Licata G
    J Card Fail; 2011 Apr; 17(4):331-9. PubMed ID: 21440872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
    Fukui M; Tsujino T; Hirotani S; Ito H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Kawabata M; Masuyama T
    Heart Vessels; 2017 Jul; 32(7):865-871. PubMed ID: 28105515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of hyponatremia with plasma renin activity, antidiuretic hormone and brain natriuretic peptide in chronic heart failure].
    Fu L; Ge HL; Li J; Chen GY; Li YS; Xie RS; Fan CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):781-3. PubMed ID: 17217682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
    Missouris CG; Grouzmann E; Buckley MG; Barron J; MacGregor GA; Singer DR
    Clin Sci (Lond); 1998 Jun; 94(6):591-9. PubMed ID: 9854456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.
    Morris AA; Nayak A; Ko YA; D'Souza M; Felker GM; Redfield MM; Tang WHW; Testani JM; Butler J
    Circ Heart Fail; 2020 Jul; 13(7):e006827. PubMed ID: 32635768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure.
    Paterna S; Fasullo S; Di Pasquale P
    Clin Drug Investig; 2005; 25(3):165-73. PubMed ID: 17523765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-aldosterone system can respond to furosemide in patients with hyperkalemic hyporeninism.
    Chan R; Sealey JE; Michelis MF; Swan A; Pfaffle AE; Devita MV; Zabetakis PM
    J Lab Clin Med; 1998 Sep; 132(3):229-35. PubMed ID: 9735929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.